Profil
Kjetil Taskén was the founder of Serca Pharmaceuticals AS, founded in 2018, and Lauras AS, founded in 1998, where the title held was Director, VP-Research & Development in 2010.
Dr. Taskén is currently the Director at the Biotechnology Centre of Oslo since 2003, the Director-Institute for Cancer Research at Oslo universitetssykehus HF since 2018, the Director at the Centre For Molecular Medicine Norway, the Professor at the University of Oslo since 2001, and a Member of The Norwegian Academy of Science & Letters.
Former positions include Director at PCI Biotech Holding ASA from 2008 to 2018, Director at Bio Medisinsk Innovasjon AS, Director at siRNAsense AS, Director at Chemlex AS, and Director at Biomedical Innovation AS.
Education includes a doctorate from the University of Oslo.
Aktiva positioner av Kjetil Taskén
| Företag | Position | Start |
|---|---|---|
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2001-01-01 |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services Operates as a nationwide organization that encompasses all scientific disciplinary services | Företagsledare/Principal | - |
Biotechnology Centre of Oslo | Direktör/Styrelseledamot | 2003-01-01 |
Centre For Molecular Medicine Norway | Direktör/Styrelseledamot | - |
Oslo universitetssykehus HF
Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Operates hospitals and provides children's health information services through online | Företagsledare/Principal | 2018-01-01 |
Tidigare kända positioner av Kjetil Taskén
| Företag | Position | Slut |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Direktör/Styrelseledamot | 2018-05-01 |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops drug treatment products for injuries | Grundare | - |
Bio Medisinsk Innovasjon AS
Bio Medisinsk Innovasjon AS BiotechnologyHealth Technology Engages in the development of biotechnology, bio-medical and pharmaceutical businesses | Direktör/Styrelseledamot | - |
Biomedical Innovation AS | Direktör/Styrelseledamot | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Kjetil Taskéns utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
PCI Biotech Holding ASA
PCI Biotech Holding ASA BiotechnologyHealth Technology Develops photochemical drug delivery technology for use in therapeutic treatment | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lauras AS
Lauras AS Miscellaneous Commercial ServicesCommercial Services Develops drugs for immunostimulating therapy | Commercial Services |
Bio Medisinsk Innovasjon AS
Bio Medisinsk Innovasjon AS BiotechnologyHealth Technology Engages in the development of biotechnology, bio-medical and pharmaceutical businesses | Health Technology |
siRNAsense AS
siRNAsense AS Miscellaneous Commercial ServicesCommercial Services Focuses on developing pipeline drugs | Commercial Services |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services Operates as a nationwide organization that encompasses all scientific disciplinary services | Commercial Services |
Chemlex AS | |
Biomedical Innovation AS | |
Biotechnology Centre of Oslo | |
Oslo universitetssykehus HF
Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Operates hospitals and provides children's health information services through online | Health Services |
Centre For Molecular Medicine Norway | |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops drug treatment products for injuries | Health Technology |
















